The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.
I am a member of the Center for Translational and Policy Research on Precision Medicine (TRANSPERS). I am interested in the ways that insurance coverage and health policy shape differential access and uptake of precision medicine. I am particularly interested in applying my research towards efforts...
I am a member of the Center for Translational and Policy Research on Precision Medicine (TRANSPERS). I work on applied and methods research to understand the clinical and economic value of drugs and other health technologies.
“Whole genome sequencing of pharmacogenetic drug response in racially diverse children with asthma” has been published by the American Journal of Respiratory and Critical Care Medicine (ARJCCM).
Marquitta White (right), MS, PhD, a postdoctoral fellow in the Burchard Lab, took on five young summer research students of diverse backgrounds, including Maria Contreras (left) and Oona Risse-Adams (center), a 16-year-old sophomore at Lowell High School in San Francisco.
The photograph of Martin Luther King Jr. hanging on the wall of the Asthma Collaboratory lab in UC San Francisco’s Rock Hall serves a reminder to all who toil there, purifying DNA samples or analyzing genetic, social or environmental data that their research is also part of a dream of equality and...
Studies of pharmacogenetics testing of pharmacy students as a teaching tool, an improved system to resolve medication issues after patients go home from the hospital, and the prophylactic use of an antiseizure drug for brain surgery patients took top honors at the Department of Clinical Pharmacy...
Marquitta White (left), MS, PhD, and Esteban Burchard, MD, MPH. Photo by Noah Berger
Results from the largest single study of the genetic and environmental causes of asthma in African American children suggest that only a tiny fraction of known genetic risk factors for the disease apply to this population.
For the 36th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.
